{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:04:22Z","timestamp":1776445462242,"version":"3.51.2"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.peptides.2010.08.005","type":"journal-article","created":{"date-parts":[[2010,8,15]],"date-time":"2010-08-15T08:36:41Z","timestamp":1281861401000},"page":"2135-2140","source":"Crossref","is-referenced-by-count":33,"title":["Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model"],"prefix":"10.1016","volume":"31","author":[{"given":"Andrea","family":"Bedini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Baiula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Gentilucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Tolomelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santi","family":"Spampinato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.peptides.2010.08.005_bib0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2377-9-S1-S3","article-title":"Characteristics of compounds that cross the blood\u2013brain barrier","volume":"9","author":"Banks","year":"2009","journal-title":"BMC Neurol"},{"key":"10.1016\/j.peptides.2010.08.005_bib0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pain.2004.08.029","article-title":"Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells","volume":"112","author":"Brack","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.peptides.2010.08.005_bib0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02245071","article-title":"Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay","volume":"115","author":"Broadbear","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.peptides.2010.08.005_bib0020","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1021\/js960067d","article-title":"How structural features influence the biomembrane permeability of peptides","volume":"85","author":"Burton","year":"1996","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.peptides.2010.08.005_bib0025","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1021\/jm011059z","article-title":"Endomorphin-1 analogues containing beta-proline are mu-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance","volume":"45","author":"Cardillo","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.peptides.2010.08.005_bib0030","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1021\/jm0498811","article-title":"Synthesis and evaluation of the affinity toward mu-opioid receptors of atypical, lipophilic ligands based on the sequence c[-Tyr-Pro-Trp-Phe-Gly-]","volume":"47","author":"Cardillo","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.peptides.2010.08.005_bib0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1476-5381.1968.tb00973.x","article-title":"The abdominal constriction response and its suppression by analgesic drugs in the mouse","volume":"32","author":"Collier","year":"1968","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1016\/j.peptides.2010.08.005_bib0040","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1460-9568.1993.tb00506.x","article-title":"Potent analgesia induced in rats by combined action at PCP and polyamine recognition sites of the NMDA receptor complex","volume":"5","author":"Coderre","year":"1993","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.peptides.2010.08.005_bib0045","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0022-3565(25)12215-5","article-title":"Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration","volume":"275","author":"Craft","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2010.08.005_bib0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1124\/pr.59.1.3","article-title":"The endomorphin system and its evolving neurophysiological role","volume":"59","author":"Fichna","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.peptides.2010.08.005_bib0055","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1208\/aapsj070482","article-title":"Transport systems for opioid peptides in mammalian tissues","volume":"7","author":"Ganapathy","year":"2005","journal-title":"AAPS J"},{"key":"10.1016\/j.peptides.2010.08.005_bib0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1749-6632.2000.tb06675.x","article-title":"Peripheral opioid modulation of visceral pain","volume":"909","author":"Gebhart","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.peptides.2010.08.005_bib0065","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1111\/j.1742-4658.2008.06386.x","article-title":"Investigation of the interaction between the atypical agonist c[YpwFG] and MOR","volume":"275","author":"Gentilucci","year":"2008","journal-title":"FEBS J"},{"key":"10.1016\/j.peptides.2010.08.005_bib0070","first-page":"12","article-title":"Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse","volume":"12","author":"Haley","year":"1957","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2010.08.005_bib0075","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1749-6632.2002.tb04247.x","article-title":"Opioid peptides endomorphin-1 and endomorphin-2 in the immune system in humans and in a rodent model of inflammation","volume":"966","author":"Jessop","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.peptides.2010.08.005_bib0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s002210100736","article-title":"Saturable brain-to-blood transport of endomorphins","volume":"139","author":"Kastin","year":"2001","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.peptides.2010.08.005_bib0085","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-3565(24)38937-2","article-title":"Analgesic synergy between topical lidocaine and topical opioids","volume":"295","author":"Kolesnikov","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2010.08.005_bib0090","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1523\/JNEUROSCI.4349-05.2006","article-title":"Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain","volume":"26","author":"Labuz","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.peptides.2010.08.005_bib0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainres.2007.05.049","article-title":"Relative contribution of peripheral versus central opioid receptors to antinociception","volume":"1160","author":"Labuz","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2010.08.005_bib0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-2999(02)01715-6","article-title":"Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal","volume":"445","author":"Lewanowitsch","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2010.08.005_bib0105","first-page":"976","article-title":"Analgesic effect of endomorphin-1","volume":"22","author":"Li","year":"2001","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.peptides.2010.08.005_bib0110","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.bjp.0705837","article-title":"Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain","volume":"142","author":"Machelska","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2010.08.005_bib0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0165-5728(02)00049-8","article-title":"Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain","volume":"126","author":"Mousa","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.peptides.2010.08.005_bib0120","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/0024-3205(86)90217-1","article-title":"Multiple mu opiate receptors","volume":"38","author":"Pasternak","year":"1986","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2010.08.005_bib0125","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/0024-3205(91)90155-5","article-title":"Comparison of naloxonazine and beta funaltrexamine antagonism of mu 1 and mu 2 opioid actions","volume":"48","author":"Pick","year":"1991","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2010.08.005_bib0130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0891-0618(00)00042-9","article-title":"Immunocytochemical mapping of endomorphin-2-immunoreactivity in rat brain","volume":"18","author":"Pierce","year":"2000","journal-title":"J Chem Neuroanat"},{"issue":"1 Suppl.","key":"10.1016\/j.peptides.2010.08.005_bib0135","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.pmn.2007.11.005","article-title":"Emerging trends and new approaches to acute pain management","volume":"9","author":"Polomano","year":"2008","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.peptides.2010.08.005_bib0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-2999(01)01308-5","article-title":"Opioids in chronic pain","volume":"429","author":"Przewlocki","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2010.08.005_bib0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0304-3959(00)00365-1","article-title":"Peripheral and preemptive opioid antinociception in a mouse visceral pain model","volume":"89","author":"Reichert","year":"2001","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.peptides.2010.08.005_bib0150","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0196-9781(02)00016-5","article-title":"Differential antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by naloxonazine and 3-methylnaltrexone","volume":"23","author":"Sakurada","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.08.005_bib0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-2999(99)00181-8","article-title":"Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception","volume":"372","author":"Sakurada","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2010.08.005_bib0160","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00001756-199804200-00014","article-title":"Immunofluorescent identification of endomorphin-2-containing nerve fibers and terminals in the rat brain and spinal cord","volume":"9","author":"Schreff","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.peptides.2010.08.005_bib0165","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0022-3565(25)12701-8","article-title":"Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered corticotropin-releasing factor in mice","volume":"254","author":"Song","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2010.08.005_bib0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-2999(03)01736-9","article-title":"Antinociception by a peripherally administered novel endomorphin-1 analogue containing beta-proline","volume":"469","author":"Spampinato","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2010.08.005_bib0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coph.2008.12.009","article-title":"Peripheral mechanisms of opioid analgesia","volume":"9","author":"Stein","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.peptides.2010.08.005_bib0180","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.peptides.2010.03.029","article-title":"Analytical characterization and comparison of the blood-brain barrier permeability of eight opioid peptides","volume":"31","author":"Van Dorpe","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.08.005_bib0185","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11095-010-0053-6","article-title":"Identification of peptide ligands for targeting to the blood-brain barrier","volume":"27","author":"van Rooy","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.peptides.2010.08.005_bib0190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2008.01.011","article-title":"Novel d-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors","volume":"583","author":"Vanderah","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2010.08.005_bib0195","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.1208\/aapsj080109","article-title":"CNS drug delivery: opioid peptides and the blood-brain barrier","volume":"8","author":"Witt","year":"2006","journal-title":"AAPS J"},{"key":"10.1016\/j.peptides.2010.08.005_bib0200","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/386499a0","article-title":"A potent and selective endogenous agonist for the mu-opiate receptor","volume":"386","author":"Zadina","year":"1997","journal-title":"Nature"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978110003451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978110003451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T14:41:08Z","timestamp":1740408068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978110003451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0196978110003451"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2010.08.005","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}